Industrial Technology Research Institute

Modetex Biomedical Materials & Technology Industrial Corp.

Ying-Chu Shih

Lain-Tze Lee

Yi-Ching Lee

Cheng-Yu Lee

Jir-Mehng Lo

Tien-Soung Tong

Jenn-Line Sheu

Ying-Fei Tsai

Kuo-Kuei Huang

Jui-Hung Yen

Chih-Hung Chen

Hsin-Hsin Shen

Hui-Ping Tsai

On Lee

Yi-Cheng Cheng

Chih-Peng Liu

Chrong-Shiong Hwang

Yen-Chun Chen

Ting-Shou Chen

Yu-Chou Chao

Meng-Nan Lin

Yuan-Jang Tsai

Jennline Sheu

Ching-Huai Ko

Kuei-Tai Lai

Ling-Mei Wang

Hui-Ju Liang

Nai-Yun Hu

Wan-Chun Liu

Bie-Shung Tsai

Ming-Kuang Shih

Lain-tze Lee

A method for treating liver fibrosis. The method includes administering to a subject suffering from liver fibrosis a pharmaceutically active extract obtained from aspecies. Also disclosed is a method for regenerating liver tissue and a method for improving a liver function.

Boehmeria extract and its use in treating liver diseases

An extract ofsp. in use of arthritis treatment is provided. The extract ofsp. and an active ingredient contained therein, antofine, are applicable to a method, pharmaceutical composition and dietary supplement for treatment of arthritis. A mass production of antofine from plant extracts is also provided.

[object Object]

A method for treating or relieving inflammatory bowel disease (IBD) is provided, including administering an extract ofas an active ingredient to a subject. Themay be selected from the group consisting ofand a combination thereof.

Method for treating or relieving inflammatory bowel disease

A pharmaceutical composition for alleviating or treating gout and the applications thereof are provided. The pharmaceutical composition includes p-coumaryl diacetate as an active ingredient.

Pharmaceutical composition for alleviating or treating gout and uses thereof

A pharmaceutical composition with an immunomodulating function is provided, including an extract ofobtained by grinding the, adding the groundto a solvent and isolating the extract from the solvent, wherein thecomprisesand Bupleurums with at least one of the nucleotide sequences selected from a group consisting of SEQ ID NOs. 1&#x2dc;6 and a nucleotide sequence with no more than 1% of the nucleotide sequence divergences of SEQ ID NOs. 1&#x2dc;6, or combinations thereof.

Pharmaceutical composition with immunomodulating function

Disclosed herein is a hydrophilic foam. The hydrophilic foam includes a polyurethane matrix having a plurality of cells. The cells are capable of retaining water in an amount of least about 8 grams of water per gram of the hydrophilic foam.

Hydrophilic foam and pharmaceutical dosage form employing the same

The invention is related to novel azulene-oxindole compounds having formula (I) shown below, wherein one of R, Rand Rrepresents a moiety of formula (II), each of Aand Aindependently is nitrogen, oxygen or sulfur, each of the others of R, R, R, R, R, R, R, R, R, R, R, R, R, and Ris as recited in the specification. The novel compound potentially inhibits multiple kinases and thus can be used to treat some disease like cancer or inflammatory. 

Azulene-oxindole compounds as multiple-kinase inhibitors and useful as anticancer agents

Growing community of inventors

Hsinchu County, Taiwan

Ying-Chu Shih